Skip to content
S9192Senate2023-2024 SessionSame asA9716

Cover Chronic Pain Treatments

Official title

“Provides insurance coverage for chronic pain”

Sponsor Gustavo RiveraSD-33Affects Finance
Status
In Senate Committee
Insurance
Impact
8/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires insurance policies in New York to cover outpatient, non-opioid treatments for chronic pain on terms comparable to opioid treatments.

Why it matters

  1. Addresses barriers to non-opioid pain treatments. by requiring insurance coverage for options like physical therapy, acupuncture, behavioral therapy, and other integrative treatments—potentially making these alternatives more affordable and accessible for people with chronic pain.

  2. Limits insurers’ ability to favor opioids over non-opioid treatments. by mandating that financial requirements (such as deductibles, copays, and visit limits) for non-opioid therapies cannot be stricter than those for opioid-based treatments or for most other medical benefits, reducing incentives to prescribe opioids due to insurance design.

  3. Defines and standardizes what counts as “chronic pain” and “non-opioid treatment”. to ensure consistent application across different insurance plans, reducing ambiguity for patients and providers seeking coverage for such treatments.

  4. Could shift clinical practice and public health outcomes. by making it easier for patients and doctors to choose safer non-opioid therapies, potentially helping to reduce the risk of opioid dependency and associated societal costs.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Cover Chronic Pain Treatments

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

No co-sponsors yet.

History

  1. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9716Assembly

Cover Chronic Pain Treatments

In Assembly Committee · Insurance · Sponsor Amy Paulin

Impact 8 · Significant0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9192

IN SENATE

May 3, 2024

Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to providing insurance coverage for chronic pain

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:

(39) (A) Every policy that provides medical, major medical, or similar comprehensive-type coverage that provides coverage for pain management services shall provide outpatient coverage for non-opioid treatment of chronic pain including complementary and integrative treatments. Access to non-opioid treatment shall be comparable to that of other covered services. Coverage shall be comparable for services provided by licensed professionals.

(B) Coverage under this subsection shall not apply financial requirements or treatment limitations to non-opioid treatment of chronic pain that are more restrictive than either of the following: the predominant financial requirements and treatment limitations applied to substantially all medical benefits covered by the contract; and the financial requirements and treatment limitations applied to any opioid-based treatment of chronic pain.

(C) For the purposes of this paragraph the following terms shall have the following meanings:

(i) "financial requirement" means deductible, co-payments, co-insurance and out-of-pocket expenses;

(ii) "predominant" means that a financial requirement or treatment limitation is the most common or frequent of such type of limit or requirement;

(iii) "treatment limitation" means limits on the frequency of treatment, number of visits, days of coverage, or other similar limits on the scope or duration of treatment and includes non-quantitative treatment limitations such as: medical management standards limiting or excluding benefits based on medical necessity, or based on whether the treatment

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD15062-01-4

is experimental or investigational; standards for provider admission to participate in a network, including reimbursement rates; methods for determining usual, customary and reasonable charges; exclusions based on failure to complete a course of treatment; and restrictions based on geographic location, facility type, provider specialty, and other criteria that limit the scope or duration of benefits for services provided under the contract; and

(iv) "Chronic pain" means pain that persists or recurs for more than three months.

§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 22 to read as follows:

(22) (A) Every insurer delivering a group or blanket policy or issuing a group or blanket policy for delivery in this state that provides coverage for pain management services shall provide outpatient coverage for non-opioid treatment of chronic pain including complementary and integrative treatments. Access to non-opioid treatment shall be comparable to that of other covered services. Coverage shall be comparable for services provided by licensed professionals.

(B) Coverage under this subsection shall not apply financial requirements or treatment limitations to non-opioid treatment of chronic pain that are more restrictive than either of the following: the predominant financial requirements and treatment limitations applied to substantially all medical benefits covered by the contract; and the financial requirements and treatment limitations applied to any opioid-based treatment of chronic pain.

(C) For the purposes of this paragraph the following terms shall have the following meanings:

(i) "financial requirement" means deductible, co-payments, co-insurance and out-of-pocket expenses;

(ii) "predominant" means that a financial requirement or treatment limitation is the most common or frequent of such type of limit or requirement;

(iii) "treatment limitation" means limits on the frequency of treatment, number of visits, days of coverage, or other similar limits on the scope or duration of treatment and includes non-quantitative treatment limitations such as: medical management standards limiting or excluding benefits based on medical necessity, or based on whether the treatment is experimental or investigational; standards for provider admission to participate in a network, including reimbursement rates; methods for determining usual, customary and reasonable charges; exclusions based on failure to complete a course of treatment; and restrictions based on geographic location, facility type, provider specialty, and other criteria that limit the scope or duration of benefits for services provided under the contract; and

(iv) "chronic pain" means pain that persists or recurs for more than three months.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (vv) to read as follows:

(vv) (1) Every contract issued by a hospital service corporation, health service corporation or medical expense indemnity corporation that includes coverage for pain management services shall provide outpatient coverage for non-opioid treatment of chronic pain including complementary and integrative treatments. Access to non-opioid treatment shall be comparable to that of other covered services. Coverage shall be comparable for services provided by licensed professionals.

(2) Coverage under this subsection shall not apply financial requirements or treatment limitations to non-opioid treatment of chronic pain that are more restrictive than either of the following: the predominant financial requirements and treatment limitations applied to substantially all medical benefits covered by the contract; and the financial requirements and treatment limitations applied to any opioid-based treatment of chronic pain.

(3) For the purposes of this subsection the following terms shall have the following meanings:

(A) "financial requirement" means deductible, co-payments, co-insurance and out-of-pocket expenses;

(B) "predominant" means that a financial requirement or treatment limitation is the most common or frequent of such type of limit or requirement;

(C) "treatment limitation" means limits on the frequency of treatment, number of visits, days of coverage, or other similar limits on the scope or duration of treatment and includes non-quantitative treatment limitations such as: medical management standards limiting or excluding benefits based on medical necessity, or based on whether the treatment is experimental or investigational; standards for provider admission to participate in a network, including reimbursement rates; methods for determining usual, customary and reasonable charges; exclusions based on failure to complete a course of treatment; and restrictions based on geographic location, facility type, provider specialty, and other criteria that limit the scope or duration of benefits for services provided under the contract; and

(D) "chronic pain" means pain that persists or recurs for more than three months.

§ 4. This act shall take effect the first day of January next succeeding the day on which it shall have become a law and shall apply to all policies and contracts issued, renewed, modified, altered, or amended on or after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law, in relation to providing insurance coverage for chronic pain

Purpose of bill

Provides outpatient insurance coverage for non-opioid treatment of chronic pain including complementary and integrative treatments.

Summary of provisions

OF BILL:

Read the full memo (652 words)

Section 1 amends subsection (i) of section 3216 of the insurance law by adding a new paragraph 39 to require policies offering medical, major medical, or similar comprehensive coverage to include outpatient cover- age for non-opioid treatment of chronic pain, encompassing complementary and integrative treatments and this coverage would be on par with other covered services and provided by licensed professionals. Notably, the provision prohibits imposing financial requirements or treatment limita- tions on non-opioid chronic pain treatment that are more restrictive than those for medical benefits in general or for opioid-based chronic pain treatment. Key definitions are provided such as "financial require- ment," "predominant," "treatment limitation," and "chronic pain," to ensure clarity and consistency in implementation.

Section 2 amends subsection (1) of section 3221 of the insurance law by adding a new paragraph 22, extending coverage for pain management services in group or blanket insurance policies, substantially similar to those outlined in section 1.

Section 3 amends subsection 303 of the insurance law by adding a new subsection (vv) to extend coverage for pain management services in contracts issued by hospital service corporations, health service corpo- rations, or medical expense indemnity corporations, substantially simi- lar to those outlined in section 1.

Section 4 provides the effective date.

Justification

Chronic pain affects millions of individuals across the United States, spanning a spectrum of conditions such as arthritis, migraines, cancer, neuropathic pain, and more. Unfortunately, conventional approaches to managing chronic pain often rely heavily on opioid medications, despite their well-documented risks of addiction, overdose, and other adverse effects. This reliance on opioids not only poses significant health risks to patients but also contributes to the ongoing opioid epidemic, which has ravaged communities nationwide.

Fortunately, there exists a diverse array of non-opioid treatments for chronic pain, which have demonstrated efficacy in managing certain types of chronic pain according to the Federal Centers for Disease Control and Prevention and the National Institutes of Health. Additionally, non- pharmacological interventions such as acupuncture and chiropractic care, physical therapy, and cognitive-behavioral therapy offer alternative

approaches to pain management that can be both effective and safer than opioids.

However, access to these non-opioid treatments has been limited for many individuals, often due to barriers such as lack of insurance coverage and financial constraints. The proposed bill seeks to address this disparity by mandating insurance coverage for non-opioid treatments for chronic pain, encompassing both pharmacological and non-pharmacological interventions. By ensuring that these treatments are readily accessible and on par with conventional medical benefits, the bill aims to remove financial barriers and treatment limitations that may prevent individ- uals from seeking alternative pain management options.

In doing so, the bill not only empowers patients to explore safer and more effective alternatives to opioids but also promotes a holistic approach to pain management that considers the individual needs and preferences of each patient. Moreover, by expanding access to non-opioid treatments, including medication, the bill has the potential to mitigate the risks associated with opioid use and contribute to border efforts to combat the opioid epidemic.

This bill represents a significant step towards addressing a critical public health issue and advancing the well-being of individuals with chronic pain across the nation. By promoting evidence-based, patient- centered care and reducing reliance on opioids, the bill underscores a commitment to fostering safer, more sustainable approaches to pain management in the state of New York.

Legislative history

New bill.

Fiscal implications for state and local governments

Undetermined.

Effective date

Effective as of the first day of January following the enactment of the law, applying to all policies, and contracts issues, renewed, modified, altered or amended on or after that date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.